![Albert Tsai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert Tsai
Keine laufenden Positionen mehr
Profil
Albert Tsai is Chief Medical Officer at VivaVision Biotech (Zhejiang) Co., Ltd. since 2025.
Formerly, Dr. Tsai was Vice President at PPD, Inc. from 2019 to 2021 and Chief Medical Officer at Zhaoke Ophthalmology Ltd. Education includes an MBA from the University of Southern California and a doctorate from Northwestern University.
Aktive Positionen von Albert Tsai
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Albert Tsai
| Unternehmen | Position | Ende |
|---|---|---|
| PPD, INC. | Corporate Officer/Principal | 01.01.2021 |
| ZHAOKE OPHTHALMOLOGY LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Albert Tsai
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PPD, Inc.
 PPD, Inc. BiotechnologyHealth Technology Engages in research and development of biopharmaceutical industry | Health Technology |
Zhaoke Ophthalmology Ltd.
 Zhaoke Ophthalmology Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies ophthalmic topical drugs | Health Technology |
